Kinnevik AB invests USD 41m in Livongo Health Inc. as part of a total capital of USD 105m, through which Kinnevik increases its shares to 8 percent. Livongo is a digital healthcare company based in the United States that helps people with chronic diseases to live better and healthier lives. "We are pleased to take a leading role in Livongo and to increase our shareholding in the company. The investment in Livongo is an important part of our strategy of identifying the winners in our private portfolio" says Georgi Ganev, CEO of Kinnevik.
